The factor VIII/Von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of Von Willebrand factor

被引:0
|
作者
Eikenboom, JCJ
Castaman, G
Kamphuisen, PW
Rosendaal, FR
Bertina, RM
机构
[1] Leiden Univ, Med Ctr, Ctr Hemostasis & Thrombosis Res, Dept Hematol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands
[3] San Bortolo Hosp, Hemophilia & Thrombosis Ctr, Dept Hematol, Vicenza, Italy
关键词
factor VIII; Willebrand; mutations; blood group; null alleles;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is often stated that a decrease in Von Willebrand factor (VWF), the carrier protein of factor VIII, results in a concordant change in factor VIII. Clinical data suggest that this is not always the case and we hypothesized that the ratio between factor VIII and VWF depends on the genetic defect that causes the VWF deficiency. We have analyzed the ratio between plasma factor VIII and VWF in several subtypes of Von Willebrand Disease and we show that the ratio is increased when VWF synthesis is reduced. but that the ratio remains one when VWF clearance is increased. These observations could be of clinical importance as an increased factor VIII/VWF ratio in combination with a borderline VWF level may indicate the presence of a true genetic defect, possibly a VWF null allele.
引用
收藏
页码:252 / 257
页数:6
相关论文
共 50 条
  • [1] Clearance mechanisms of von Willebrand factor and factor VIII
    Lenting, P. J.
    van Schooten, C. J. M.
    Denis, C. V.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (07) : 1353 - 1360
  • [2] Factor VIII and von Willebrand factor
    Vlot, AJ
    Koppelman, SJ
    Bouma, BN
    Sixma, JJ
    THROMBOSIS AND HAEMOSTASIS, 1998, 79 (03) : 456 - 465
  • [3] Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease
    Batlle, Javier
    Fernanda Lopez-Fernandez, Maria
    Loures Fraga, Esther
    Rodriguez Trillo, Angela
    Almudena Perez-Rodriguez, Maria
    BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (02) : 89 - 100
  • [4] Clearance of von Willebrand factor
    Denis, Cecile V.
    Christophe, Olivier D.
    Oortwijn, Beatrijs D.
    Lenting, Peter J.
    THROMBOSIS AND HAEMOSTASIS, 2008, 99 (02) : 271 - 278
  • [5] Clearance of von Willebrand factor
    Casari, C.
    Lenting, P. J.
    Wohner, N.
    Christophe, O. D.
    Denis, C. V.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 202 - 211
  • [6] Evaluation of von Willebrand factor activity in factor VIII/von Willebrand factor concentrates with the automated von Willebrand factor: activity IL test
    Mori, Filippo
    Rossi, Paola
    Nardini, Ilaria
    Gambelli, Davide
    Farina, Claudio
    BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (03) : 221 - 228
  • [7] von Willebrand Factor and Factor VIII Clearance in Perioperative Hemophilia A Patients
    van Moort, Iris
    Bukkems, Laura H.
    Heijdra, Jessica M.
    Schutgens, Roger E. G.
    Laros-van Gorkom, Britta A. P.
    Nieuwenhuizen, Laurens
    van der Meer, Felix J. M.
    Fijnvandraat, Karin
    Ypma, Paula
    de Maat, Moniek P. M.
    Leebeek, FrankW. G.
    Meijer, Karina
    Eikenboom, Jeroen
    Mathot, Ron A. A.
    Cnossen, Marjon H.
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (07) : 1056 - 1065
  • [8] Optimizing therapy with factor VIII von Willebrand factor concentrates in von Willebrand disease
    Federici, AB
    Mannucci, PM
    HAEMOPHILIA, 1998, 4 : 7 - 10
  • [9] Pharmacokinetics of von Willebrand factor and factor VIII in canine von Willebrand disease and haemophilia A
    Stokol, T
    Trepanier, L
    Parry, BW
    Finnin, BC
    RESEARCH IN VETERINARY SCIENCE, 1997, 63 (01) : 23 - 27
  • [10] Detection of type 1 von Willebrand Disease with increased von Willebrand Factor clearance
    Meiring, M.
    Setlaba, P.
    Coetzee, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1147 - 1147